1. Home
  2. EVLV vs COLL Comparison

EVLV vs COLL Comparison

Compare EVLV & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.36

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.17

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
COLL
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
EVLV
COLL
Price
$6.36
$32.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$9.13
$51.40
AVG Volume (30 Days)
3.3M
413.4K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
$780,567,000.00
Revenue This Year
$21.67
$8.01
Revenue Next Year
$19.50
N/A
P/E Ratio
N/A
$77.65
Revenue Growth
N/A
23.62
52 Week Low
$4.61
$29.08
52 Week High
$8.90
$50.79

Technical Indicators

Market Signals
Indicator
EVLV
COLL
Relative Strength Index (RSI) 49.03 42.20
Support Level $5.40 $31.56
Resistance Level $6.83 $35.95
Average True Range (ATR) 0.26 1.21
MACD 0.03 -0.30
Stochastic Oscillator 59.44 42.20

Price Performance

Historical Comparison
EVLV
COLL

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: